Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer

12 Jul 2023

Abstract excerpt

BACKGROUND: The N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) is the only writer responsible for DNA 6mA modifications. At present, its role in cancer is still unclear, and further systematic pan-cancer analysis is needed to explore its value in diagnosis, prognosis and immunological function. METHODS: The subcellular localization of N6AMT1 was explored by UniProt and HPA database. The expression data and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37437243
DOI: 10.18632/aging.204868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancerPMID 37437243Read ↗

The comprehensive analysis of the prognostic and functional role of N-terminal methyltransferases 1 in pan-cancerSemantic proximity Read ↗

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.Semantic proximity Read ↗

Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer typesSemantic proximity Read ↗

Comprehensive Multiomic Analysis Identified TUBA1C as a Potential Prognostic Biological Marker of Immune-Related Therapy in Pan-Cancer.Semantic proximity Read ↗

Pan-Cancer Analysis of Molecular Characteristics and Oncogenic Role of PRMT5 in Human CancersSemantic proximity Read ↗

Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy responseSemantic proximity Read ↗

Prognostic and Immunological Role of mRNA ac4C Regulator NAT10 in Pan-Cancer: New Territory for Cancer Research?Semantic proximity Read ↗

NSUN6, a Gene Related With m5c Methylation, May Serve as a Biomarker for Pan-cancerSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy responseSemantic proximity Read ↗

The Role of M6A-related CBLL1 in the Prognosis and Immune Infiltration of Pan-cancerSemantic proximity Read ↗

Prognostic and Immunological Role of mRNA ac4C Regulator NAT10 in Pan-Cancer: New Territory for Cancer Research?Semantic proximity Read ↗

Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.